Tekla Capital Management LLC Y M Abs Therapeutics, Inc. Transaction History

Tekla Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$27.47 - $37.31 $5.43 Million - $7.38 Million	-197,820 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$29.16 - $51.96 $3.54 Million - $6.3 Million	121,272 Added 158.43%	197,820 $5.98 Million
Q1 2020 May 14, 2020	BUY	$14.39 - $35.8 $938,544 - $2.33 Million	65,222 Added 575.86%	76,548 $2 Million
Q4 2019 Feb 13, 2020	BUY	$23.81 - $33.78 $269,672 - $382,592	11,326 New	11,326 $354,000

107

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $434M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.